The FDA Decision and Its Implications for Indoor Tanning
The withdrawal of a 2015 proposal by the U.S. Food and Drug Administration (FDA) that aimed to prevent minors from using tanning beds has stirred tremendous concern among dermatologists and other healthcare professionals. This decision marks a significant shift in policy regarding youth access to potentially harmful ultraviolet (UV) radiation.
Understanding the FDA's Withdrawal
The proposal, initially introduced in 2015, sought to bar individuals under 18 years from using tanning beds and mandated that prospective users acknowledge the risks prior to use. Despite the proposed safety measures, the FDA formally withdrew the proposal citing "scientific and technical concerns" and potential "unintended consequences." The decision was made public through the Federal Register, yet the precise reasons for the discontinuation and the timing of this decision remain unclear.
When approached by Medscape Medical News, an FDA spokesperson clarified that withdrawing the proposal was meant to indicate that the planned action would not be finalized. This move has left many experts puzzled about the underlying motivations.
Health Risks of Indoor Tanning
The contentious nature of the FDA’s decision stems largely from the well-documented health risks associated with indoor tanning. Dr. Susan C. Taylor, president of the American Academy of Dermatology, expressed disappointment, emphasizing that UV radiation exposure from indoor tanning is a known risk factor for melanoma and nonmelanoma skin cancers.
Statistics underline the dangers: using tanning beds before the age of 20 can increase the risk of melanoma by 47%, and the likelihood escalates with continued use. Adolescents who engage in indoor tanning before age 18 often maintain this habit into adulthood. Dr. Taylor highlighted the critical necessity of limiting teens' access to tanning services and educating the public on its dangers as vital measures to curb skin cancer incidences.
Recent studies from Northwestern University reinforce these concerns. Their findings reveal that frequent tanning bed users may face up to an eightfold increased risk for melanoma compared to non-users deemed at high risk. Tanning beds have been shown to cause alterations in DNA linked to melanoma on a molecular level, and the damage often affects areas of skin not typically exposed to natural sunlight.
Rising Melanoma Rates in the United States
The rates of melanoma cases have been rising steadily in the United States, with data from the National Cancer Institute showing an average annual increase of 1.2% from 2013 to 2022. Dr. Bobby Mukkamala of the American Medical Association (AMA) reiterated concerns that indoor tanning, particularly at a young age, significantly raises the risk of developing melanoma and other skin cancers.
The AMA has consistently supported restrictions on youth access to indoor tanning, formalizing its stance through a policy introduced in 2019, which advocated for stronger warnings against UVA radiation dangers.
Disappointment in the Dermatology Community
For many professionals in the field, the FDA's withdrawal of the proposal represents a step backwards. Dr. Kavita Mariwalla, president of the American Society for Dermatologic Surgery, voiced her disappointment, arguing that this action undermines the message that tanning beds pose a clear cancer risk. Despite efforts to educate the public, Dr. Mariwalla noted that adolescents remain especially vulnerable to the harmful effects of UV radiation, given the severity of the impact before age 18 on future cancer risks.
Dr. Deborah S. Sarnoff, president of The Skin Cancer Foundation, echoed the sentiment, lamenting the decision's potential effects on public health. Having devoted her career to treating skin cancer and witnessing the toll it takes on young lives, Dr. Sarnoff emphasized the dangers posed by UV-emitting devices, classified as carcinogenic by the World Health Organization in 2009. Data from The Skin Cancer Foundation indicate a 75% heightened melanoma risk for individuals using tanning beds before age 35.
Regional Restrictions on Tanning Bed Use
Despite the absence of federal regulation, several states have enacted their own prohibitions on minors’ access to tanning beds. In 2014, the FDA had reclassified sunlamps from low-risk (Class I) to higher-risk (Class II) devices, requiring stronger safety warnings for products or promotional materials aimed at minors. Nonetheless, the tanning industry itself isn’t directly regulated under these rules.
Currently, 22 states and Washington, DC, have laws banning indoor tanning for minors under 18, while another 22 states impose certain restrictions on minors' tanning bed use. Yet the lack of federal legislation leaves legislation largely to the states, and the FDA's recent withdrawal may hinder further legislative progress by removing a scientific foundation for legal measures.
Future Prospects for FDA Policy
While the FDA's recent decision marks a significant regression in federal protections against tanning bed use among minors, it doesn’t necessarily close the door on future regulatory efforts. The agency clarified that withdrawal "does not preclude" revisiting the issue, and strongly encourages discussions between potential tanning bed users and healthcare providers about the associated risks.
Healthcare professionals like Dr. Taylor and Dr. Mukkamala hope for renewed attention from the FDA on this perilous health matter. There is a strong call within the medical community to reintroduce the withdrawn proposal or similar regulations to ensure protection against unnecessary risks and to reflect a comprehensive acknowledgment of the scientific evidence supporting such actions.
Overall, while the FDA's decision represents a setback, it underscores the persistent health challenge posed by indoor tanning and the continued advocacy needed to overcome regulatory hurdles to safeguard public health.
출처 : Original Source